Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes

We estimated the effectiveness of booster doses of monovalent mRNA COVID-19 vaccines against Omicron-associated severe outcomes among adults in Ontario, Canada. We used a test-negative design to estimate vaccine effectiveness (VE) against hospitalization or death among SARS-CoV-2-tested adults aged...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Nature communications Ročník 14; číslo 1; s. 1273 - 10
Hlavní autori:	Grewal, Ramandip, Nguyen, Lena, Buchan, Sarah A., Wilson, Sarah E., Nasreen, Sharifa, Austin, Peter C., Brown, Kevin A., Fell, Deshayne B., Gubbay, Jonathan B., Schwartz, Kevin L., Tadrous, Mina, Wilson, Kumanan, Kwong, Jeffrey C.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London Nature Publishing Group UK 07.03.2023 Nature Publishing Group Nature Portfolio
Predmet:	631/326/590 631/326/596/4130 692/700/459/1748 692/700/478/174 Adult Adults Coronaviruses COVID-19 COVID-19 - prevention & control COVID-19 Vaccines Effectiveness Humanities and Social Sciences Humans Immunization Immunization, Secondary mRNA multidisciplinary Ontario - epidemiology RNA, Messenger SARS-CoV-2 Science Science (multidisciplinary) Severe acute respiratory syndrome coronavirus 2 Vaccine efficacy Vaccines Ontario Ontario Canada Canada
ISSN:	2041-1723, 2041-1723
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!